XIN SHELLEY WANG to Hematologic Neoplasms
This is a "connection" page, showing publications XIN SHELLEY WANG has written about Hematologic Neoplasms.
Connection Strength
0.354
-
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies. Transplant Cell Ther. 2021 11; 27(11):930.e1-930.e10.
Score: 0.354